Our findings also offer novel insights into the transcriptional regulation of IL10 in DN patients, suggesting that these polymorphisms may modulate IL10 expression via altered interactions with transcription factors such as CEBPA and KLF4. This evidence concerns the gene IL10 and liver dysplastic nodule.